Indian cinema is going through the same transition private equity took in the 1990s and venture capital took in the 2000s — from an asset class transacted on handshakes to one transacted on structures. Family offices, HNIs, and accredited capital that ten years ago would not have considered film investment now sit on committees evaluating it. This primer covers what has changed and what serious capital needs to ask before allocating.
The structural shift.
Five things changed between 2018 and 2026. First, OTT platforms (Netflix, Prime, Hotstar, JioCinema, Sony LIV) created a second commercial window for films that did not depend on theatrical box office. Second, audit standards on film SPVs improved, partly because OTT platforms demanded entity-level transparency. Third, brand placement matured into a rate-carded ancillary revenue stream. Fourth, regulatory clarity on accredited-investor structures improved through SEBI's evolving frameworks. Fifth, a generation of producers who grew up in private equity entered the industry and brought structures with them.
The net effect: a serious film financing today looks like a small private equity deal. Named SPV, documented IP, transparent recoupment waterfall, defined exits.
What capital should ask.
Ten questions, in order.
- Who owns the IP, and is that ownership documented in the SPV constitution?
- What is the recoupment waterfall? In what order do investors recoup before profit share triggers?
- What is the lock-in window, and what triggers an early exit?
- Who is the executive producer, and what is their track record on delivery?
- What is the distribution strategy — theatrical-first, OTT-first, hybrid?
- What brand placement deals are already structured? At what value?
- What is the marketing budget, and who controls it?
- Who audits the SPV? Annual statements, frequency?
- What is the realistic exit timeline — 24 months, 36 months, 48 months?
- What happens if the film does not get made — what is the capital protection on script-stage or pre-production failure?
A well-structured film SPV has documented answers to all ten. A poorly structured one will be vague on three or more.
Considering an allocation to Indian cinema?
The Bridge — Photopandits' film investment vertical — provides structured exposure with full IP transparency, SPV-anchored deals, and quarterly reporting. Book a confidential call to discuss your mandate.
Book a confidential call →The revenue stack, plainly.
A 2026 Hindi feature film, mid-budget, expects revenue from: theatrical box office (window 1, weeks 1–6), OTT first-window licensing (window 2, months 2–4), satellite licensing (window 3, months 6–12), music rights, brand placement (paid at production, recognised at release), international and regional language rights, and merchandising. The dependence on theatrical has fallen dramatically. OTT first-window deals are now the single largest revenue line for most mid-budget Indian features.
The risk profile, plainly.
Film investment risk is bimodal — the project gets made and earns, or it gets made and does not earn (or doesn't get made at all). The middle scenarios are rarer than in other asset classes. Diversification within a slate (4–8 projects rather than 1) materially reduces variance. This is why fund structures often outperform single-project SPVs for risk-adjusted returns.
The return profile, plainly.
Mid-budget Indian features (₹15–60 crore production budget) historically deliver 1.5x–3x recoupment in 24–36 months when they hit, and partial recoupment when they do not. Premium OTT series (₹40–120 crore) deliver 1.4x–2.5x in 18–30 months. Documentaries and festival-route content typically deliver lower but more predictable returns through licensing windows. Theatrical-only blockbuster bets deliver 5x+ when they hit and zero when they do not.
A diversified slate basket targeting 12–18% IRR over a 4-year cycle is achievable at the institutional level. Capital seeking returns above 25% IRR is typically taking on excessive concentration risk.
The brand placement upside.
Brand placement on Indian web series and films has matured into a contractually rate-carded revenue line. A premium series with rate-carded placements across 8 episodes can generate ₹6–12 crore in placement revenue alone, recognised at release. For investors, this is recoupment cushion that derisks the underlying production. Funds that systematically incorporate brand placement into the underwriting outperform those that treat it as upside.
What capital should not do.
Three common mistakes. First, do not invest at the script stage without a producer attached and a star letter of intent. Pre-script risk is too high for non-specialist capital. Second, do not invest without contractual exit clarity. Vague exit clauses become protracted negotiations when the film earns. Third, do not invest based on the star's name alone — the producer's execution track record matters more than the star.
The Bridge structures all of these as standard. If your current film investment opportunity does not, ask why.
